![]() |
|||||||||
Home | Mission | Keynote Speaker | Abstract Submission | Registration | Agenda | Venue | Past Events | Organizers | Contacts |
Keynote Speaker: |
||
|
|||||||||||
Scott Halperin, MD |
|||||||||||
Professor of Pediatrics and Associate Professor of Microbiology & Immunology, Dalhousie University Director of Canadian Center for Vaccinology, IWK Health Centre
|
|||||||||||
Research Program (taken from Dalhousie Infectious Disease Research Alliance (DIDRA)): Dr. Halperin's laboratory research originally focused on pertussis and protective antigens of Bordetella pertussis; his clinical and epidemiological research related to the diagnosis and treatment of pertussis. In 1991, he broadened his research to include clinical trials involving vaccines (pertussis and others). In 1992, Dr. Halperin established the Clinical Trials Research Center, which has grown to over 30 staff involved in the design, performance, management, analysis, and reporting of clinical trials related to infections in children. Dr. Halperin established collaboration with Dr. Song Lee through DIDRA, and they are currently using the animal model of pertussis to explore the feasibility of an oral vaccine against pertussis. This vaccine uses Streptococcus gordonii expressing genes for pertussis protective antigens. Publications: Recent Publications (Pubmed) Research Profile: IWK Health Care |
|||||||||||